Table of Contents 1 Parkinson's Disease Therapeutics Market Overview 1.1 Product Overview and Scope of Parkinson's Disease Therapeutics 1.2 Classification of Parkinson's Disease Therapeutics by Types 1.2.1 Global Parkinson's Disease Therapeutics Revenue Comparison by Types (2019-2024) 1.2.2 Global Parkinson's Disease Therapeutics Revenue Market Share by Types in 2018 1.2.3 Medications Therapeutics 1.2.4 Medical Devices Therapeutics 1.3 Global Parkinson's Disease Therapeutics Market by Application 1.3.1 Global Parkinson's Disease Therapeutics Market Size and Market Share Comparison by Applications (2014-2024) 1.3.2 Under 40 Years Old 1.3.3 40-65 Years Old 1.3.4 Above 65 Years Old 1.4 Global Parkinson's Disease Therapeutics Market by Regions 1.4.1 Global Parkinson's Disease Therapeutics Market Size (Million USD) Comparison by Regions (2014-2024) 1.4.1 North America (USA, Canada and Mexico) Parkinson's Disease Therapeutics Status and Prospect (2014-2024) 1.4.2 Europe (Germany, France, UK, Russia and Italy) Parkinson's Disease Therapeutics Status and Prospect (2014-2024) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Parkinson's Disease Therapeutics Status and Prospect (2014-2024) 1.4.4 South America (Brazil, Argentina, Colombia) Parkinson's Disease Therapeutics Status and Prospect (2014-2024) 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Parkinson's Disease Therapeutics Status and Prospect (2014-2024) 1.5 Global Market Size of Parkinson's Disease Therapeutics (2014-2024) 2 Manufacturers Profiles 2.1 GSK 2.1.1 Business Overview 2.1.2 Parkinson's Disease Therapeutics Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 GSK Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.2 Novartis 2.2.1 Business Overview 2.2.2 Parkinson's Disease Therapeutics Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Novartis Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.3 Boehringer Ingelheim 2.3.1 Business Overview 2.3.2 Parkinson's Disease Therapeutics Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Boehringer Ingelheim Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.4 Teva Pharmaceutical 2.4.1 Business Overview 2.4.2 Parkinson's Disease Therapeutics Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Teva Pharmaceutical Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.5 Abbvie 2.5.1 Business Overview 2.5.2 Parkinson's Disease Therapeutics Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Abbvie Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.6 Merck 2.6.1 Business Overview 2.6.2 Parkinson's Disease Therapeutics Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Merck Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.7 Akorn 2.7.1 Business Overview 2.7.2 Parkinson's Disease Therapeutics Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Akorn Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.8 Kyowa Hakko Kirin Pharma 2.8.1 Business Overview 2.8.2 Parkinson's Disease Therapeutics Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.9 Astellas Pharma 2.9.1 Business Overview 2.9.2 Parkinson's Disease Therapeutics Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 Astellas Pharma Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.10 Desitin Arzneimittel 2.10.1 Business Overview 2.10.2 Parkinson's Disease Therapeutics Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 Desitin Arzneimittel Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.11 Endo Pharmaceuticals 2.11.1 Business Overview 2.11.2 Parkinson's Disease Therapeutics Type and Applications 2.11.2.1 Product A 2.11.2.2 Product B 2.11.3 Endo Pharmaceuticals Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.12 F.Hoffmann-La Roche 2.12.1 Business Overview 2.12.2 Parkinson's Disease Therapeutics Type and Applications 2.12.2.1 Product A 2.12.2.2 Product B 2.12.3 F.Hoffmann-La Roche Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.13 H.Lundbeck 2.13.1 Business Overview 2.13.2 Parkinson's Disease Therapeutics Type and Applications 2.13.2.1 Product A 2.13.2.2 Product B 2.13.3 H.Lundbeck Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.14 Valeant 2.14.1 Business Overview 2.14.2 Parkinson's Disease Therapeutics Type and Applications 2.14.2.1 Product A 2.14.2.2 Product B 2.14.3 Valeant Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.15 Apokyn 2.15.1 Business Overview 2.15.2 Parkinson's Disease Therapeutics Type and Applications 2.15.2.1 Product A 2.15.2.2 Product B 2.15.3 Apokyn Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.16 Orion 2.16.1 Business Overview 2.16.2 Parkinson's Disease Therapeutics Type and Applications 2.16.2.1 Product A 2.16.2.2 Product B 2.16.3 Orion Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.17 Stada Arzneimittel 2.17.1 Business Overview 2.17.2 Parkinson's Disease Therapeutics Type and Applications 2.17.2.1 Product A 2.17.2.2 Product B 2.17.3 Stada Arzneimittel Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.18 US WorldMeds 2.18.1 Business Overview 2.18.2 Parkinson's Disease Therapeutics Type and Applications 2.18.2.1 Product A 2.18.2.2 Product B 2.18.3 US WorldMeds Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.19 Valeant Pharmaceuticals 2.19.1 Business Overview 2.19.2 Parkinson's Disease Therapeutics Type and Applications 2.19.2.1 Product A 2.19.2.2 Product B 2.19.3 Valeant Pharmaceuticals Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 3 Global Parkinson's Disease Therapeutics Market Competition, by Players 3.1 Global Parkinson's Disease Therapeutics Revenue and Share by Players (2014-2019) 3.2 Market Concentration Rate 3.2.1 Top 5 Parkinson's Disease Therapeutics Players Market Share 3.2.2 Top 10 Parkinson's Disease Therapeutics Players Market Share 3.3 Market Competition Trend 4 Global Parkinson's Disease Therapeutics Market Size by Regions 4.1 Global Parkinson's Disease Therapeutics Revenue and Market Share by Regions 4.2 North America Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) 4.3 Europe Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) 4.4 Asia-Pacific Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) 4.5 South America Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) 4.6 Middle East and Africa Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) 5 North America Parkinson's Disease Therapeutics Revenue by Countries 5.1 North America Parkinson's Disease Therapeutics Revenue by Countries (2014-2019) 5.2 USA Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) 5.3 Canada Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) 5.4 Mexico Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) 6 Europe Parkinson's Disease Therapeutics Revenue by Countries 6.1 Europe Parkinson's Disease Therapeutics Revenue by Countries (2014-2019) 6.2 Germany Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) 6.3 UK Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) 6.4 France Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) 6.5 Russia Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) 6.6 Italy Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) 7 Asia-Pacific Parkinson's Disease Therapeutics Revenue by Countries 7.1 Asia-Pacific Parkinson's Disease Therapeutics Revenue by Countries (2014-2019) 7.2 China Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) 7.3 Japan Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) 7.4 Korea Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) 7.5 India Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) 7.6 Southeast Asia Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) 8 South America Parkinson's Disease Therapeutics Revenue by Countries 8.1 South America Parkinson's Disease Therapeutics Revenue by Countries (2014-2019) 8.2 Brazil Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) 8.3 Argentina Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) 8.4 Colombia Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) 9 Middle East and Africa Revenue Parkinson's Disease Therapeutics by Countries 9.1 Middle East and Africa Parkinson's Disease Therapeutics Revenue by Countries (2014-2019) 9.2 Saudi Arabia Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) 9.3 UAE Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) 9.4 Egypt Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) 9.5 Nigeria Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) 9.6 South Africa Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) 10 Global Parkinson's Disease Therapeutics Market Segment by Type 10.1 Global Parkinson's Disease Therapeutics Revenue and Market Share by Type (2014-2019) 10.2 Global Parkinson's Disease Therapeutics Market Forecast by Type (2019-2024) 10.3 Medications Therapeutics Revenue Growth Rate (2014-2024) 10.4 Medical Devices Therapeutics Revenue Growth Rate (2014-2024) 11 Global Parkinson's Disease Therapeutics Market Segment by Application 11.1 Global Parkinson's Disease Therapeutics Revenue Market Share by Application (2014-2019) 11.2 Parkinson's Disease Therapeutics Market Forecast by Application (2019-2024) 11.3 Under 40 Years Old Revenue Growth (2014-2019) 11.4 40-65 Years Old Revenue Growth (2014-2019) 11.5 Above 65 Years Old Revenue Growth (2014-2019) 12 Global Parkinson's Disease Therapeutics Market Size Forecast (2019-2024) 12.1 Global Parkinson's Disease Therapeutics Market Size Forecast (2019-2024) 12.2 Global Parkinson's Disease Therapeutics Market Forecast by Regions (2019-2024) 12.3 North America Parkinson's Disease Therapeutics Revenue Market Forecast (2019-2024) 12.4 Europe Parkinson's Disease Therapeutics Revenue Market Forecast (2019-2024) 12.5 Asia-Pacific Parkinson's Disease Therapeutics Revenue Market Forecast (2019-2024) 12.6 South America Parkinson's Disease Therapeutics Revenue Market Forecast (2019-2024) 12.7 Middle East and Africa Parkinson's Disease Therapeutics Revenue Market Forecast (2019-2024) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source

List of Tables and Figures Figure Parkinson's Disease Therapeutics Picture Table Product Specifications of Parkinson's Disease Therapeutics Table Global Parkinson's Disease Therapeutics and Revenue (Million USD) Market Split by Product Type Figure Global Parkinson's Disease Therapeutics Revenue Market Share by Types in 2018 Figure Medications Therapeutics Picture Figure Medical Devices Therapeutics Picture Table Global Parkinson's Disease Therapeutics Revenue (Million USD) by Application (2014-2024) Figure Parkinson's Disease Therapeutics Revenue Market Share by Applications in 2018 Figure Under 40 Years Old Picture Figure 40-65 Years Old Picture Figure Above 65 Years Old Picture Table Global Market Parkinson's Disease Therapeutics Revenue (Million USD) Comparison by Regions 2014-2024 Figure North America Parkinson's Disease Therapeutics Revenue (Million USD) and Growth Rate (2014-2024) Figure Europe Parkinson's Disease Therapeutics Revenue (Million USD) and Growth Rate (2014-2024) Figure Asia-Pacific Parkinson's Disease Therapeutics Revenue (Million USD) and Growth Rate (2014-2024) Figure South America Parkinson's Disease Therapeutics Revenue (Million USD) and Growth Rate (2014-2024) Figure Middle East and Africa Parkinson's Disease Therapeutics Revenue (Million USD) and Growth Rate (2014-2024) Figure Global Parkinson's Disease Therapeutics Revenue (Million USD) and Growth Rate (2014-2024) Table GSK Basic Information, Manufacturing Base and Competitors Table GSK Parkinson's Disease Therapeutics Type and Applications Table GSK Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table Novartis Basic Information, Manufacturing Base and Competitors Table Novartis Parkinson's Disease Therapeutics Type and Applications Table Novartis Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors Table Boehringer Ingelheim Parkinson's Disease Therapeutics Type and Applications Table Boehringer Ingelheim Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors Table Teva Pharmaceutical Parkinson's Disease Therapeutics Type and Applications Table Teva Pharmaceutical Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table Abbvie Basic Information, Manufacturing Base and Competitors Table Abbvie Parkinson's Disease Therapeutics Type and Applications Table Abbvie Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table Merck Basic Information, Manufacturing Base and Competitors Table Merck Parkinson's Disease Therapeutics Type and Applications Table Merck Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table Akorn Basic Information, Manufacturing Base and Competitors Table Akorn Parkinson's Disease Therapeutics Type and Applications Table Akorn Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table Kyowa Hakko Kirin Pharma Basic Information, Manufacturing Base and Competitors Table Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Type and Applications Table Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table Astellas Pharma Basic Information, Manufacturing Base and Competitors Table Astellas Pharma Parkinson's Disease Therapeutics Type and Applications Table Astellas Pharma Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table Desitin Arzneimittel Basic Information, Manufacturing Base and Competitors Table Desitin Arzneimittel Parkinson's Disease Therapeutics Type and Applications Table Desitin Arzneimittel Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table Endo Pharmaceuticals Basic Information, Manufacturing Base and Competitors Table Endo Pharmaceuticals Parkinson's Disease Therapeutics Type and Applications Table Endo Pharmaceuticals Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table F.Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors Table F.Hoffmann-La Roche Parkinson's Disease Therapeutics Type and Applications Table F.Hoffmann-La Roche Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table H.Lundbeck Basic Information, Manufacturing Base and Competitors Table H.Lundbeck Parkinson's Disease Therapeutics Type and Applications Table H.Lundbeck Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table Valeant Basic Information, Manufacturing Base and Competitors Table Valeant Parkinson's Disease Therapeutics Type and Applications Table Valeant Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table Apokyn Basic Information, Manufacturing Base and Competitors Table Apokyn Parkinson's Disease Therapeutics Type and Applications Table Apokyn Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table Orion Basic Information, Manufacturing Base and Competitors Table Orion Parkinson's Disease Therapeutics Type and Applications Table Orion Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table Stada Arzneimittel Basic Information, Manufacturing Base and Competitors Table Stada Arzneimittel Parkinson's Disease Therapeutics Type and Applications Table Stada Arzneimittel Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table US WorldMeds Basic Information, Manufacturing Base and Competitors Table US WorldMeds Parkinson's Disease Therapeutics Type and Applications Table US WorldMeds Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table Valeant Pharmaceuticals Basic Information, Manufacturing Base and Competitors Table Valeant Pharmaceuticals Parkinson's Disease Therapeutics Type and Applications Table Valeant Pharmaceuticals Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table Global Parkinson's Disease Therapeutics Revenue (Million USD) by Players (2014-2019) Table Global Parkinson's Disease Therapeutics Revenue Share by Players (2014-2019) Figure Global Parkinson's Disease Therapeutics Revenue Share by Players in 2017 Figure Global Parkinson's Disease Therapeutics Revenue Share by Players in 2018 Figure Global Top 5 Players Parkinson's Disease Therapeutics Revenue Market Share in 2018 Figure Global Top 10 Players Parkinson's Disease Therapeutics Revenue Market Share in 2018 Figure Global Parkinson's Disease Therapeutics Revenue (Million USD) and Growth Rate (%) (2014-2019) Table Global Parkinson's Disease Therapeutics Revenue (Million USD) by Regions (2014-2019) Table Global Parkinson's Disease Therapeutics Revenue Market Share by Regions (2014-2019) Figure Global Parkinson's Disease Therapeutics Revenue Market Share by Regions (2014-2019) Figure Global Parkinson's Disease Therapeutics Revenue Market Share by Regions in 2018 Figure North America Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) Figure Europe Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) Figure Asia-Pacific Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) Figure South America Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) Figure Middle East and Africa Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) Table North America Parkinson's Disease Therapeutics Revenue by Countries (2014-2019) Table North America Parkinson's Disease Therapeutics Revenue Market Share by Countries (2014-2019) Figure North America Parkinson's Disease Therapeutics Revenue Market Share by Countries (2014-2019) Figure North America Parkinson's Disease Therapeutics Revenue Market Share by Countries in 2018 Figure USA Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) Figure Canada Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) Figure Mexico Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) Table Europe Parkinson's Disease Therapeutics Revenue (Million USD) by Countries (2014-2019) Figure Europe Parkinson's Disease Therapeutics Revenue Market Share by Countries (2014-2019) Figure Europe Parkinson's Disease Therapeutics Revenue Market Share by Countries in 2018 Figure Germany Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) Figure UK Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) Figure France Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) Figure Russia Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) Figure Italy Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) Table Asia-Pacific Parkinson's Disease Therapeutics Revenue (Million USD) by Countries (2014-2019) Figure Asia-Pacific Parkinson's Disease Therapeutics Revenue Market Share by Countries (2014-2019) Figure Asia-Pacific Parkinson's Disease Therapeutics Revenue Market Share by Countries in 2018 Figure China Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) Figure Japan Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) Figure Korea Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) Figure India Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) Figure Southeast Asia Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) Table South America Parkinson's Disease Therapeutics Revenue by Countries (2014-2019) Table South America Parkinson's Disease Therapeutics Revenue Market Share by Countries (2014-2019) Figure South America Parkinson's Disease Therapeutics Revenue Market Share by Countries (2014-2019) Figure South America Parkinson's Disease Therapeutics Revenue Market Share by Countries in 2018 Figure Brazil Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) Figure Argentina Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) Figure Colombia Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) Table Middle East and Africa Parkinson's Disease Therapeutics Revenue (Million USD) by Countries (2014-2019) Table Middle East and Africa Parkinson's Disease Therapeutics Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Parkinson's Disease Therapeutics Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Parkinson's Disease Therapeutics Revenue Market Share by Countries in 2018 Figure Saudi Arabia Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) Figure UAE Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) Figure Egypt Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) Figure Nigeria Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) Figure South Africa Parkinson's Disease Therapeutics Revenue and Growth Rate (2014-2019) Table Global Parkinson's Disease Therapeutics Revenue (Million USD) by Type (2014-2019) Table Global Parkinson's Disease Therapeutics Revenue Share by Type (2014-2019) Figure Global Parkinson's Disease Therapeutics Revenue Share by Type (2014-2019) Figure Global Parkinson's Disease Therapeutics Revenue Share by Type in 2019 Table Global Parkinson's Disease Therapeutics Revenue Forecast by Type (2019-2024) Figure Global Parkinson's Disease Therapeutics Market Share Forecast by Type (2019-2024) Figure Global Medications Therapeutics Revenue Growth Rate (2014-2019) Figure Global Medical Devices Therapeutics Revenue Growth Rate (2014-2019) Table Global Parkinson's Disease Therapeutics Revenue by Application (2014-2019) Table Global Parkinson's Disease Therapeutics Revenue Share by Application (2014-2019) Figure Global Parkinson's Disease Therapeutics Revenue Share by Application (2014-2019) Figure Global Parkinson's Disease Therapeutics Revenue Share by Application in 2019 Table Global Parkinson's Disease Therapeutics Revenue Forecast by Application (2019-2024) Figure Global Parkinson's Disease Therapeutics Market Share Forecast by Application (2019-2024) Figure Global Under 40 Years Old Revenue Growth Rate (2014-2019) Figure Global 40-65 Years Old Revenue Growth Rate (2014-2019) Figure Global Above 65 Years Old Revenue Growth Rate (2014-2019) Figure Global Parkinson's Disease Therapeutics Revenue (Million USD) and Growth Rate Forecast (2019-2024) Table Global Parkinson's Disease Therapeutics Revenue (Million USD) Forecast by Regions (2019-2024) Figure Global Parkinson's Disease Therapeutics Revenue Market Share Forecast by Regions (2019-2024) Figure North America Parkinson's Disease Therapeutics Revenue Market Forecast (2019-2024) Figure Europe Parkinson's Disease Therapeutics Revenue Market Forecast (2019-2024) Figure Asia-Pacific Parkinson's Disease Therapeutics Revenue Market Forecast (2019-2024) Figure South America Parkinson's Disease Therapeutics Revenue Market Forecast (2019-2024) Figure Middle East and Africa Parkinson's Disease Therapeutics Revenue Market Forecast (2019-2024)

GSK Novartis Boehringer Ingelheim Teva Pharmaceutical Abbvie Merck Akorn Kyowa Hakko Kirin Pharma Astellas Pharma Desitin Arzneimittel Endo Pharmaceuticals F.Hoffmann-La Roche H.Lundbeck Valeant Apokyn Orion Stada Arzneimittel US WorldMeds Valeant Pharmaceuticals